Pharmacy
School of Pharmacy
- Location
- Belfast, United Kingdom
- Funding
- See university guidance
- Application deadline
- See university guidance
About the project
How do tumours hijack proteases to grow, spread and evade treatment? Dr Burden's research tackles this question by exploring the fundamental biology of proteases in cancer and inflammation. Using advanced molecular and cellular approaches, her group aims to uncover druggable pathways, discover new biomarkers and develop the foundations for next-generation therapies. This work sits at the interface of basic science and drug discovery, with the ultimate goal of improving outcomes for cancer patients.
- Dr Roberta Burden: School of Pharmacy
Contact info
- View Academic Profile
- r.burden@qub.ac.uk
Research Interests
Open to PhD applications in the fields of:
Make a PhD enquiry
- Protease biology
- Drug target validation
- Preclinical evaluation of small molecule and biologic inhibitors
- Cancer biology and therapeutic targeting
- Tumour microenvironment research
- Translational pharmacology
Public outreach & key achievements
Cathepsin V regulates cell cycle progression and histone stability in the nucleus of breast cancer cells. Sereesongsaeng N, Burrows JF, Scott CJ, Brix K, Burden RE. Front Pharmacol. 2023 Nov 6;14:1271435.
Lysosomal cysteine proteases are mediators of cell death in macrophages following exposure to amorphous silica nanoparticles. Ishaq F, Sereesongsaeng N, Johnston MC, Scott CJ, Burden RE. Chem Biol Interact. 2022 Apr 1;356:109882.
Cathepsin V suppresses GATA3 protein expression in luminal A breast cancer. Sereesongsaeng N, McDowell SH, Burrows JF, Scott CJ, Burden RE. Breast Cancer Res. 2020;22(1):139.
Procathepsin V Is Secreted in a TSH Regulated Manner from Human Thyroid Epithelial Cells and Is Accessible to an Activity-Based Probe. Al-Hashimi A, Venugopalan V, Rehders M, Sereesongsaeng N, Hein Z, Springer S, Weber E, Führer D, Bogyo MS, Scott CJ, Burden RE, Brix K. Int J Mol Sci. 2020;21(23):9140.
Significance of nuclear cathepsin V in normal thyroid epithelial and carcinoma cells. Al-Hashimi A, Venugopalan V, Sereesongsaeng N, Tedelind S, Pinzaru AM, Hein Z, Springer S, Weber E, Führer D, Scott CJ, Burden RE, Brix K. Biochim Biophys Acta Mol Cell Res. 2020;1867(12):118846.
A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast Cancer. Wilkinson RDA, Burden RE, McDowell SH, McArt DG, McQuaid S, Bingham V, Williams R, Cox ÓT, O'Connor R, McCabe N, Kennedy RD, Buckley NE, Scott CJ. J Oncol. 2019;2019:3980273.
A bioavailable cathepsin S nitrile inhibitor abrogates tumor development. Wilkinson RD, Young A, Burden RE, Williams R, Scott CJ. Mol Cancer. 2016;15:29.
Extracellular cathepsin S and intracellular caspase 1 activation are surrogate biomarkers of particulate-induced lysosomal disruption in macrophages. Hughes CS, Colhoun LM, Bains BK, Kilgour JD, Burden RE, Burrows JF, Lavelle EC, Gilmore BF, Scott CJ. Part Fibre Toxicol. 2016;13:19.
CCL2 is transcriptionally controlled by the lysosomal protease cathepsin S in a CD74-dependent manner. Wilkinson RD, Magorrian SM, Williams R, Young A, Small DM, Scott CJ, Burden RE. Oncotarget. 2015;6(30):29725-39.
Research students
PhD Title | Assessing the Molecular Mechanisms by which Cathepsin V Promotes Breast Cancer Growth and Metastasis
Name | Lauren McCosh
Years of study | 2024 - 2027
Country | Northern Ireland
PhD Title | Elucidating the Involvement of Cathepsin V in Pathobiological Mechanisms Promoting Cancer
Name | Yingming Zhou
Years of study | 2024 - 2027
Country | China
PhD Title | Exploring the Functional and Therapeutic Significance of Cathepsin V in ER-Positive Breast Cancer
Name | Yin Sing Low
Years of study | 2025 - 2028
Country | Malaysia
PhD Title | Mechanistic Dissection of Nuclear Protease Function in Tumour Biology
Name | Jamie Cunningham
Years of study | 2026 - 2029
Country | Northern Ireland
Alumni: Where are they now
PhD Title | Characterisation of the protease Cathepsin S as a novel therapeutic target in Triple-Negative Breast Cancer.
Name | Sara McDowell
Years of study | 2018 - 2022
Country | Northern Ireland
Current position | PDRA, Future Medicines Institute/Ulster University
PhD Title | Dissecting the role of Cathepsin V in breast cancer.
Name | Naphannop Sereesongsaeng
Years of study | 2017 - 2020
Country | Thailand
Current position | Higher Scientific Officer, Institute of Cancer Research, London.
PhD Title | Evaluation of nanoparticle treatment on intracellular protease activity profiles.
Name | Fatima Ishaq
Years of study | 2015 - 2018
Country | Nigeria
Current position | Lecturer, College of Nursing Science, Nigeria.
Discover More
- Faculty of Medicine, Health & Life Sciences
- School of Pharmacy
- LinkedIn profile